 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
|
|
|
|
Phase III
|
|
|
|
ECOG-E1302
E1302, NCT00088907
|
|
| |
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
|
|
|
|
Phase III
|
|
|
|
IRB 13362B
NCT00117572
|
|
| |
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
|
|
|
|
Phase III
|
|
|
|
COG-ARAR0331
ARAR0331, NCT00274937
|
|
| |
Nutrition and Resistance Training in Head and Neck Cancer
|
|
|
|
Phase III
|
|
|
|
080219
NCT00696553
|
|
| |
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
UCIRB #14735B
GV-001.010 (TNF-ELF), NCT00496236
|
|
| |
A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
UCIRB #14733B
GV-001.011 (TNF-CORE), NCT00496535
|
|
| |
Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck
|
|
|
|
Phase II, Phase I
|
|
|
|
07-069
NCT00570674
|
|
| |
A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck
|
|
|
|
Phase II
|
|
|
|
12652A
NCT00203905
|
|
| |
Pemetrexed Chemotherapy in Poor-Risk Patients With Advanced Head and Neck Cancer
|
|
|
|
Phase II
|
|
|
|
OSU-0482
NCT00293579
|
|
| |
Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck
|
|
|
|
Phase II
|
|
|
|
H-26154 (GCC 0442)
CA225092, NCT00343083
|
|
